| Characterizing a thermostable Cas9 for bacterial genome editing and silencing I Mougiakos, P Mohanraju, EF Bosma, V Vrouwe, M Finger Bou, ... Nature communications 8 (1), 1647, 2017 | 148 | 2017 |
| Next generation prokaryotic engineering: the CRISPR-Cas toolkit I Mougiakos, EF Bosma, WM de Vos, R van Kranenburg, J van der Oost Trends in biotechnology 34 (7), 575-587, 2016 | 142 | 2016 |
| Hijacking CRISPR-Cas for high-throughput bacterial metabolic engineering: advances and prospects I Mougiakos, EF Bosma, J Ganguly, J van der Oost, R van Kranenburg Current Opinion in Biotechnology 50, 146-157, 2018 | 83 | 2018 |
| Efficient genome editing of a facultative thermophile using mesophilic spCas9 I Mougiakos, EF Bosma, K Weenink, E Vossen, K Goijvaerts, ... ACS synthetic biology 6 (5), 849-861, 2017 | 73 | 2017 |
| Cas12a2 elicits abortive infection through RNA-triggered destruction of dsDNA O Dmytrenko, GC Neumann, T Hallmark, DJ Keiser, VM Crowley, ... Nature 613 (7944), 588-594, 2023 | 34 | 2023 |
| Efficient Cas9-based genome editing of Rhodobacter sphaeroides for metabolic engineering I Mougiakos, E Orsi, MR Ghiffary, W Post, A de Maria, B Adiego-Perez, ... Microbial cell factories 18, 1-13, 2019 | 27 | 2019 |
| Growth-uncoupled isoprenoid synthesis in Rhodobacter sphaeroides E Orsi, I Mougiakos, W Post, J Beekwilder, M Dompè, G Eggink, ... Biotechnology for Biofuels 13, 1-13, 2020 | 17 | 2020 |
| Rapid cell-free characterization of multi-subunit CRISPR effectors and transposons F Wimmer, I Mougiakos, F Englert, CL Beisel Molecular Cell 82 (6), 1210-1224. e6, 2022 | 16 | 2022 |
| A hyperthermoactive-Cas9 editing tool reveals the role of a unique arsenite methyltransferase in the arsenic resistance system of Thermus thermophilus HB27 G Gallo, I Mougiakos, M Bianco, M Carbonaro, A Carpentieri, A Illiano, ... MBio 12 (6), e02813-21, 2021 | 10 | 2021 |
| Development of a Cas12a-based genome editing tool for moderate thermophiles P Mohanraju, I Mougiakos, J Albers, M Mabuchi, RT Fuchs, JL Curcuru, ... The CRISPR Journal 4 (1), 82-91, 2021 | 9 | 2021 |
| First structural insights into CRISPR-Cas-guided DNA transposition J van der Oost, I Mougiakos Cell Research 30 (3), 193-194, 2020 | 9 | 2020 |
| Cas12a2 elicits abortive infection via RNA-triggered destruction of double-stranded DNA O Dmytrenko, GC Neumann, T Hallmark, DJ Keiser, VM Crowley, ... bioRxiv, 2022.06. 13.495973, 2022 | 3 | 2022 |
| Thermostable Cas9 nucleases J Van Der Oost, R Van Kranenburg, EF Bosma, I Mougiakos, P Mohanraju US Patent 11,326,162, 2022 | 3 | 2022 |
| Thermostable cas9 nucleases J Van Der Oost, R Van Kranenburg, EF Bosma, I Mougiakos US Patent 11,242,513, 2022 | 3 | 2022 |
| Efficient Genome and Base Editing in Human Cells Using ThermoCas9 D Trasanidou, P Barendse, E Bouzetos, L de Haan, H Bouwmeester, ... The CRISPR Journal 6 (3), 278-288, 2023 | 2 | 2023 |
| CRISPR transposons on the move I Mougiakos, CL Beisel Cell Host & Microbe 29 (5), 675-677, 2021 | 2 | 2021 |
| Thermostable cas9 nucleases J Van Der Oost, R Van Kranenburg, EF Bosma, I Mougiakos, P Mohanraju US Patent App. 16/469,691, 2019 | 1 | 2019 |
| Feel the burn: a collection of stories on hot’n’sharp DNA engineering I Mougiakos PQDT-Global, 2019 | 1 | 2019 |
| Thermostable CAS9 nucleases J Van Der Oost, R Van Kranenburg, EF Bosma, I Mougiakos, P Mohanraju US Patent 11,976,306, 2024 | | 2024 |
| Thermostable Cas9 nucleases EF BOSMA, I MOUGIAKOS, J Van Der Oost, R Van Kranenburg AU Patent App. 2,016,432,443 A, 2024 | | 2024 |
